A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Alzheimer's Disease
In brief
The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.
Key facts
- Study ID
- NCT05310071
- Run by
- Biogen
- People needed
- 1027
- Starts
- 2022-06-02
- Expected to finish
- 2024-08-12
- Last updated by the study team
- 2025-04-23
Who can join
Age: 60 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Xenoscience Inc. — Phoenix, Arizona, United States
- Banner Alzheimer's Institute — Phoenix, Arizona, United States
- Barrow Neurological Institute — Phoenix, Arizona, United States
- HonorHealth Neurology — Scottsdale, Arizona, United States
- Mayo Clinic Arizona — Scottsdale, Arizona, United States
- Banner Sun Health Research Institute — Sun City, Arizona, United States
- Banner Alzheimer's Institute — Tucson, Arizona, United States
- Health Initiatives Research — Fayetteville, Arkansas, United States
- Sun Valley Behaivoral Med Center — El Centro, California, United States
- Neuropain Medical Center — Fresno, California, United States
- Neurology Center of North Orange County — Fullerton, California, United States
- Irvine Center for Clinical Research, Inc. — Irvine, California, United States
- Mary S. Easton Center for Alzheimer's Disease Research, UCLA — Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
- Stanford Hospital and Clinics — Palo Alto, California, United States
- VA Palo Alto Health Care System — Palo Alto, California, United States
- Anderson Clinical Research — Redlands, California, United States
- Sutter Health-San Francisco — San Francisco, California, United States
- University of California San Francisco (PARENT) — San Francisco, California, United States
- The Neuron Clinic — San Marcos, California, United States
- Syrentis Clinical Research — Santa Ana, California, United States
- California Neuroscience Research, LLC — Sherman Oaks, California, United States
- Viking Clinical Research Center — Temecula, California, United States
- University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
- Gilbert Neurology Partners, PLLC — Gilbert, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.